Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer revision of the page text.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page’s “Revision” indicator was updated from v3.5.2 to v3.5.3, reflecting a site/version change rather than an update to the clinical trial record.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.5.0 has been added. Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.4.3 is shown, replacing the previous v3.4.2. No study data or actionable details are altered.SummaryDifference0.1%

- Check110 days agoChange DetectedAdded Revision: v3.4.2; removed the government-funding downtime notice and the previous Revision: v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.